185 related articles for article (PubMed ID: 33305293)
1. Molecular analysis of primary melanoma T cells identifies patients at risk for metastatic recurrence.
Pruessmann W; Rytlewski J; Wilmott J; Mihm MC; Attrill GH; Dyring-Andersen B; Fields P; Zhan Q; Colebatch AJ; Ferguson PM; Thompson JF; Kallenbach K; Yusko E; Clark RA; Robins H; Scolyer RA; Kupper TS
Nat Cancer; 2020 Feb; 1(2):197-209. PubMed ID: 33305293
[TBL] [Abstract][Full Text] [Related]
2. Primary tumour ulceration in cutaneous melanoma: its role on TNM stages.
Tas F; Erturk K
Jpn J Clin Oncol; 2021 Feb; 51(2):192-198. PubMed ID: 33159197
[TBL] [Abstract][Full Text] [Related]
3. Microsatellite Instability Predicts Response to Anti-PD1 Immunotherapy in Metastatic Melanoma.
Roncati L
Acta Dermatovenerol Croat; 2018 Dec; 26(4):341-343. PubMed ID: 30665488
[TBL] [Abstract][Full Text] [Related]
4. Greater Tumor Thickness, Ulceration, and Positive Sentinel Lymph Node Are Associated With Worse Prognosis in Patients With Conjunctival Melanoma: Implications for Future AJCC Classifications.
Esmaeli B; Rubin ML; Xu S; Goepfert RP; Curry JL; Prieto VG; Ning J; Tetzlaff MT
Am J Surg Pathol; 2019 Dec; 43(12):1701-1710. PubMed ID: 31425167
[TBL] [Abstract][Full Text] [Related]
5. Mitotic rate is a more reliable unfavorable prognosticator than ulceration for early cutaneous melanoma: a 5-year survival analysis.
Donizy P; Kaczorowski M; Leskiewicz M; Zietek M; Pieniazek M; Kozyra C; Halon A; Matkowski R
Oncol Rep; 2014 Dec; 32(6):2735-43. PubMed ID: 25310673
[TBL] [Abstract][Full Text] [Related]
6. Tumor Thickness and Mitotic Rate Robustly Predict Melanoma-Specific Survival in Patients with Primary Vulvar Melanoma: A Retrospective Review of 100 Cases.
Nagarajan P; Curry JL; Ning J; Piao J; Torres-Cabala CA; Aung PP; Ivan D; Ross MI; Levenback CF; Frumovitz M; Gershenwald JE; Davies MA; Malpica A; Prieto VG; Tetzlaff MT
Clin Cancer Res; 2017 Apr; 23(8):2093-2104. PubMed ID: 27864417
[No Abstract] [Full Text] [Related]
7. CEACAM1 expression in cutaneous malignant melanoma predicts the development of metastatic disease.
Thies A; Moll I; Berger J; Wagener C; Brümmer J; Schulze HJ; Brunner G; Schumacher U
J Clin Oncol; 2002 May; 20(10):2530-6. PubMed ID: 12011132
[TBL] [Abstract][Full Text] [Related]
8. Analysis of T cell receptor alpha beta variability in tumor-infiltrating lymphocytes in primary and metastatic melanoma.
Zeuthen J; Birck A; Straten PT
Arch Immunol Ther Exp (Warsz); 1995; 43(2):123-33. PubMed ID: 8744727
[TBL] [Abstract][Full Text] [Related]
9. Molecular profiling reveals low- and high-grade forms of primary melanoma.
Harbst K; Staaf J; Lauss M; Karlsson A; Måsbäck A; Johansson I; Bendahl PO; Vallon-Christersson J; Törngren T; Ekedahl H; Geisler J; Höglund M; Ringnér M; Lundgren L; Jirström K; Olsson H; Ingvar C; Borg Å; Tsao H; Jönsson G
Clin Cancer Res; 2012 Aug; 18(15):4026-36. PubMed ID: 22675174
[TBL] [Abstract][Full Text] [Related]
10. Detailed spatial immunophenotyping of primary melanomas reveals immune cell subpopulations associated with patient outcome.
Attrill GH; Lee H; Tasker AT; Adegoke NA; Ferguson AL; da Silva IP; Saw RPM; Thompson JF; Palendira U; Long GV; Ferguson PM; Scolyer RA; Wilmott JS
Front Immunol; 2022; 13():979993. PubMed ID: 36003398
[TBL] [Abstract][Full Text] [Related]
11. BRAF immunohistochemistry predicts sentinel lymph node involvement in intermediate thickness melanomas.
Manninen AA; Gardberg M; Juteau S; Ilmonen S; Jukonen J; Andersson N; Carpén O
PLoS One; 2019; 14(4):e0216043. PubMed ID: 31039200
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma.
Clemente CG; Mihm MC; Bufalino R; Zurrida S; Collini P; Cascinelli N
Cancer; 1996 Apr; 77(7):1303-10. PubMed ID: 8608507
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database.
Thompson JF; Soong SJ; Balch CM; Gershenwald JE; Ding S; Coit DG; Flaherty KT; Gimotty PA; Johnson T; Johnson MM; Leong SP; Ross MI; Byrd DR; Cascinelli N; Cochran AJ; Eggermont AM; McMasters KM; Mihm MC; Morton DL; Sondak VK
J Clin Oncol; 2011 Jun; 29(16):2199-205. PubMed ID: 21519009
[TBL] [Abstract][Full Text] [Related]
14. A ferric reductase of Trypanosoma cruzi (TcFR) is involved in iron metabolism in the parasite.
Dick CF; de Moura Guimarães L; Carvalho-Kelly LF; Cortes AL; da Silva Lara Morcillo L; da Silva Sampaio L; Meyer-Fernandes JR; Vieyra A
Exp Parasitol; 2020 Oct; 217():107962. PubMed ID: 32763249
[TBL] [Abstract][Full Text] [Related]
15. Sentinel lymph node biopsy followed by lymph node dissection for localised primary cutaneous melanoma.
Kyrgidis A; Tzellos T; Mocellin S; Apalla Z; Lallas A; Pilati P; Stratigos A
Cochrane Database Syst Rev; 2015 May; 2015(5):CD010307. PubMed ID: 25978975
[TBL] [Abstract][Full Text] [Related]
16. The importance of ulceration of cutaneous melanoma of the head and neck: a comparison of ear (pinna) and nonear sites.
Augenstein AC; Capello ZJ; Little JA; McMasters KM; Bumpous JM
Laryngoscope; 2012 Nov; 122(11):2468-72. PubMed ID: 23108883
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical analysis of the T-cell receptor beta-chain variable regions expressed by T lymphocytes infiltrating primary human melanoma.
Clemente C; Rao S; Lupetti R; Tragni G; Pisarra P; Bersani I; Parmiani G; Mihm MC; Sensi M
Lab Invest; 1998 May; 78(5):619-27. PubMed ID: 9605186
[TBL] [Abstract][Full Text] [Related]
18. Mitotic rate in node-positive stage III melanoma: it might be as important a prognostic factor as node number.
Tas F; Erturk K
Jpn J Clin Oncol; 2021 May; 51(6):873-878. PubMed ID: 33758939
[TBL] [Abstract][Full Text] [Related]
19. Predictive accuracy of elevated mitotic rate on lymph node positivity and recurrence in thin melanomas.
Ly CL; Blaha O; Wei W; Galan A; Kluger H; Ariyan S; Olino K; Clune JE
Front Oncol; 2022; 12():1077226. PubMed ID: 36686728
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Significance of Periadnexal Extension in Cutaneous Melanoma and its Implications for Pathologic Reporting and Staging.
Dodds TJ; Lo S; Jackett L; Nieweg O; Thompson JF; Scolyer RA
Am J Surg Pathol; 2018 Mar; 42(3):359-366. PubMed ID: 29240580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
